Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...
Sanofi Consumer Healthcare India has reported 1% rise in net profit to Rs 46.35 crore on a 6.8% increase in net sales to Rs 170.70 crore in Q3 FY25 as compared with Q3 FY24.
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...
In its third-quarter results update, Sanofi said the consumer health unit – which owns brands like allergy therapies Allegra and Xyzal, irritable bowel syndrome product Buscopan, painkiller ...
Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for ... Sanofi will gain access to a number of leading brands across different categories, including digestion ...
4d
GlobalData on MSNSanofi moves closer to selling controlling stake in $17bn-valued OpellaSanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.
Besides, two new brands were launched ... Through the Scheme of Arrangement among the Company and Sanofi Consumer Healthcare India Limited, the Consumer Healthcare Business of the Company got ...
Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...
Amazon Music and WPP unveiled Louder Than Cancer, an effort uniting top global artists to harness the power of music in recognition of World Cancer Day with creative leadership from WPP’s Grey Health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results